Deepanshu Jain, MD
Gastroenterology · Celebration, FLNPI 1215377247
Payments from drug & device makers
What this record shows
This record is dominated by grants: $12,500 of the $15,951 with a category attached, or 78.4%. Boston Scientific accounts for 78.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $6,679 and has fallen 97.7% since, to $152 in 2025. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $145.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$13K
- AbbVie$714
- Ovesco Endoscopy USA, Inc.$675
- Olympus Corporation Of The Americas$539
- Medtronic$452
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$254
- plus $801 from 14 others
What the payments were for
- Grants$12,50078%
- Travel & lodging$1,0106%
- Food & beverage$2,44115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $12,516 |
| AbbVie | 37 | $714 |
| Ovesco Endoscopy USA, Inc. | 1 | $675 |
| Olympus Corporation Of The Americas | 6 | $539 |
| Medtronic | 3 | $452 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $184 |
| 3-d Matrix, Inc. | 1 | $143 |
| Bristol Myers Squibb | 8 | $121 |
| Johnson & Johnson | 5 | $83 |
| Redhill Biopharma Inc. | 6 | $77 |
| Braintree Laboratories, Inc. | 3 | $44 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Conmed Corporation | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Evoke Pharma, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,951 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 39 | $622 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Celebration
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.